WebIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of … WebIronwood Pharmaceuticals. 100 Summer Street. Suite 2300. Boston MA 02110. Entrance at the corner of Devonshire St. and Summer St. [email protected]. Tel – …
Ironwood Pharmaceuticals: Contact Details and Business Profile
WebApr 14, 2024 · The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period last year, the company earned $0.27 EPS. WebApr 12, 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $425.09 million. The company’s revenue is forecast to grow by 3.50% over what it did in 2024. A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Ironwood Pharmaceuticals Inc. highland headache relief
Ironwood Pharmaceuticals profit, revenue top views
WebIronwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. ... Total Enterprise Value to Total Revenue (ttm) 3.33. Markets data provided by S&P and by Xignite. WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. One in five Americans suffer from GI diseases, resulting in millions of hospital visits and tens of billions in healthcare costs each year. WebIronwood Pharmaceuticals. Jun 2024 - Present11 months. Boston, Massachusetts, United States. Strategic finance professional at Ironwood Pharmaceuticals, a $500M revenue commercial pharmaceuticals ... highland headland crossword